Hayley Lewis

Hayley Lewis is an accomplished executive with extensive experience in regulatory affairs and quality assurance within the pharmaceutical industry. Currently serving as Senior Vice President of Regulatory Affairs at Priovant Therapeutics since October 2021, Hayley has previously held senior leadership roles at Zosano Pharma, Carbylan Therapeutics, and Depomed, Inc., where responsibilities included overseeing regulatory compliance and managing submissions to ensure alignment with federal regulations. With a strong foundation in drug development strategy and regulatory processes across various stages of product life cycles, Hayley began her career at Nektar Therapeutics and has built a robust educational background with degrees and executive training from prestigious institutions including Stanford Graduate School of Business and Northwestern University.